glp 1 stock FDA Approves First Generic GLP-1 Liraglutide for Weight Loss 1,755 Glp 1 Drug Royalty-Free

T.AugustinR.BakhtiM.ColldenG.DruckerD

Self-harming adverse events in obesity medications are a sensitive issue

Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that was recently approved by the FDA for the treatment of type 2 diabetes

Nausea rates in retatrutide trials reached approximately 45% at the maximum dose, compared to roughly 31% for tirzepatide

Non-contrast CT of the abdomen and pelvis revealed multiple scattered diverticula and associated pericolic fat stranding, consistent with uncomplicated diverticulitis (Figure 1)